Oracle and Palantir took center stage this year as the artificial intelligence sector continued to dominate the conversation.

Though it certainly doesn’t feel like it, Oracle (NASDAQ:ORCL) shares finished 2025 with respectable, market-beating gains ...

Oracle was at the center of all things artificial intelligence (AI) in 2025, and therefore at the center of the investing ...

Oracle’s cloud and AI pivot drives revenue growth and a strong backlog, but high capex and debt pose risks. Read why I rate ...

Oracle Corp. said final negotiations on an equity deal for a data center project in Michigan are “on schedule” and doesn’t include Blue Owl Capital, a firm that has helped finance massive data center ...

With a Price to Book ratio of 18.42, which is 1.07x the industry average, Oracle might be considered overvalued in terms of ...

Oracle's 2052 bonds are offering a rare 7% yield. Read about the risks and if they're right for income-focused investors.

Hospitals and health systems are entering a period of rapid acceleration in AI. Clinical leaders are reporting tangible gains, from automated note-taking to clearer visibility into patient histories, ...

What Happened: Magouyrk's decision to sell 10,000 shares of Oracle was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the sale is ...

Paramount just confirmed Oracle founder (and father of Paramount CEO David Ellison) Larry Ellison intends to personally ...

Three health systems reported that patient information may have been involved in a data security incident tied to Cerner, the EHR vendor now known as Oracle Health. Lake Regional Health System (Osage ...

Oracle's first-quarter results, announced in September, delivered a significant positive surprise that outweighed modest revenue shortfalls. Although revenue of $14.9 billion and adjusted earnings per ...